BY MARKETWIRE
-
Novo Nordisk enters technology development partnership with German life science company
Both firms are collaborating to establish innovative modern technology for research study right into cell-based treatments for later commercialization.
-
Novo Nordisk’s semaglutide may lower risk of opioid overdose
A research study from Instance Western Get College and the National Institutes of Wellness including around 33,000 diabetes mellitus clients reveals that the Novo medication might …
-
Coloplast deputy chairman buys company shares for DKK 40m
The acquisition is made after chairman of the board Lars Rasmussen recently offered a big part of his shares in the clinical tool firm.
-
Bloomberg: Swedish equity fund EQT considering sale of stake in WS Audiology
According to the resources, EQT is dealing with Goldman Sachs to discover an ideal customer for component of the 49 percent risk the exclusive equity company keeps in WS Audiology.
-
Novo Nordisk CEO: US middlemen are cause of high prices
Supposed drug store advantage supervisors (PBMs) are in charge of acquiring medications for a variety of medical insurance strategies.
-
ALK remains optimistic about getting house dust mite vaccine to China despite challenges
China calls for even more screening.
-
Novo Nordisk CEO named leader of the year by European media
An organization of company media indicate Novo Nordisk’s chief executive officer Lars Fruergaard Jørgensen as a leader that has actually made a phenomenal initiative.
-
China takes action against counterfeit obesity drugs
In an effort to restrict an informal market in the nation, China has actually done something about it versus the unlawful manufacturing and sale of imitation variations of Novo Nor…
-
Bavarian’s smallpox and mpox vaccine approved for adolescents in the EU
The vaccination has actually been accepted by the European health and wellness authorities for usage in teens aged 12-17.
-
ALK sees great potential in the market for peanut allergy
The firm’s peanut allergic reaction injection tablet computer remains in stage I and can get in the marketplace by 2030.